- Home
- CMCL vs FENC Comparison
CMCL vs FENC Comparison
Compare CMCL & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCL | FENC |
|---|---|---|
| Founded | 1992 | 1996 |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.5M | 258.5M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | CMCL | FENC |
|---|---|---|
| Price | $26.59 | $7.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $28.00 | $13.50 |
| AVG Volume (30 Days) | ★ 252.4K | 154.3K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ 908.66 | N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | ★ $228,245,000.00 | $38,790,000.00 |
| Revenue This Year | $55.07 | N/A |
| Revenue Next Year | $6.82 | $75.22 |
| P/E Ratio | $10.41 | ★ N/A |
| Revenue Growth | ★ 38.04 | N/A |
| 52 Week Low | $8.81 | $4.68 |
| 52 Week High | $38.75 | $9.92 |
Technical Indicators
Market Signals| Indicator | CMCL | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 47.44 |
| Support Level | $23.88 | $7.50 |
| Resistance Level | $24.94 | $8.00 |
| Average True Range (ATR) | 1.36 | 0.28 |
| MACD | 0.31 | 0.03 |
| Stochastic Oscillator | 72.73 | 52.31 |
Price Performance
Historical ComparisonAbout CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.